Literature DB >> 34541108

Tumorigenicity Assay in Nude Mice.

Feng Du1, Xiaodi Zhao1, Daiming Fan1.   

Abstract

Tumorigenicity refers to the ability of cultured cells to develop viable tumors in immune-deficient animals. The goal of this protocol is to illustrate tumorigenicity assay by subcutaneous tumor-cell-transplantation in nude mice. Target cells are transplanted to 6-week-old nude mice subcutaneously and the tumor growth is monitored over a period of observation or treatment. When tumor grows to a pre-determined size or by the end of the limited period, the nude mice will be euthanatized and the xenograft will be removed for further examination.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Nude mice; Tumor cell transplantation; Tumor xenograft model; Tumorigenicity

Year:  2017        PMID: 34541108      PMCID: PMC8413503          DOI: 10.21769/BioProtoc.2364

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  5 in total

1.  Identification of nude mice in tumorigenicity assays.

Authors:  E G van Meir
Journal:  Int J Cancer       Date:  1997-04-10       Impact factor: 7.396

2.  Tumorigenicity assays in nonhuman primates treated with antithymocyte globulin.

Authors:  J C Petricciani; R L Kirchstein; J E Hines; R E Wallace; D P Martin
Journal:  J Natl Cancer Inst       Date:  1973-07       Impact factor: 13.506

3.  Transplantation of human prostatic carcinoma into nude mice in Matrigel.

Authors:  T G Pretlow; C M Delmoro; G G Dilley; C G Spadafora; T P Pretlow
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

4.  Determination of subcutaneous tumor size in athymic (nude) mice.

Authors:  M M Tomayko; C P Reynolds
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Heterotransplantation of human malignant tumors in "nude" thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors.

Authors:  B C Giovanella; J S Stehlin; L J Williams
Journal:  J Natl Cancer Inst       Date:  1974-03       Impact factor: 13.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.